Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones

被引:51
作者
Ahlen, J
Andersson, S
Mukohyama, H
Roth, C
Bäckman, A
Conaway, HH
Lerner, UH [1 ]
机构
[1] Umea Univ, Dept Oral Cell Biol, SE-90187 Umea, Sweden
[2] Umea Univ, Dept Sports Med, SE-90187 Umea, Sweden
[3] Tokyo Med & Dent Univ, Dept Maxillofacial Prosthet Maxillofacial Reconst, Tokyo, Japan
[4] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA
关键词
bone resorption; osteoclasts interleukin; interleukin-11 (IL-11); osteoprotegerin (OPG); receptor activator of nuclear factor-kappa B ligand (RANKL);
D O I
10.1016/S8756-3282(02)00784-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-11 (IL-11) is a stromal cell-derived cytokine that can enhance osteoclast formation and stimulate bone resorption. In the present study, the characteristics of the resorptive effect of IL-11 in mouse calvarial bones were investigated. Both recombinant mouse IL-11 and human IL-11 caused concentration- and time-dependent stimulations of Ca-45 release from prelabeled mouse calvariae. Half-maximal responses were obtained at 0.7 ng/mL (approximate to40 pmol/L). Mouse and human IL-11 also stimulated release of H-3 from [H-3]proline-labeled bones. The magnitude of the Ca-45 and H-3 release (1.4-1.6-fold) caused by a maximally effective concentration of IL-11 was less than the stimulation (2.5-4.0-fold) elicited by a maximum concentration of parathyroid hormone (PTH). Release of Ca-45 by IL-11 was unaffected by the mitotic inhibitors, hydroxyurea and aphidicolin. In addition to resorption of bone, IL-11 caused a small (1.5-2.0-fold) enhancement of prostaglandin E-2 (PGE(2)) biosynthesis in calvariae, but had no effect on the mRNA expression of cyclooxygenase-1 and -2, or cytosolic phospholipase A(2). Indomethacin and flurbiprofen abolished the formation of PGE(2) and partially reduced Ca-45 release stimulated by IL-11. When either mouse interleukin-4 (IL-4) or interleukin-13 (IL-13) was added to calvariae treated with IL-11, Ca-45 release was inhibited. Resorption caused by IL-11 was also inhibited by both anti-mouse glycoprotein 130 (gp130) and an antibody neutralizing IL-11, but these agents had no effect on Ca-45 release caused by PTH or 1,25(OH)(2)vitamin D-3 (D-3). Real-time, quantitative polymerase chain reaction (PCR) analysis (TaqMan PCR) and semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) demonstrated that IL-11 caused concentration-dependent enhancements of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) mRNA, without affecting the mRNA expression of RANK. Mouse RANKL stimulated Ca-45 release in the calvarial bones. The stimulatory effects of RANKL and IL-11 were inhibited by mouse OPG. These data demonstrate that IL-11 stimulates osteoclastic resorption in mouse calvariae by mechanisms that are independent of cell proliferation; partially dependent on prostaglandin biosynthesis; sensitive to inhibition by IL-4, IL-13, and OPG; and associated with enhanced expression of RANKL and OPG. In addition, IL-11 was not found to play an essential role in resorption stimulated by other calciotropic agents in calvariae.
引用
收藏
页码:242 / 251
页数:10
相关论文
共 42 条
[1]  
ABULAMER Y, 2001, J CLIN INVEST, V107, P1375
[2]   Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal osteoblastic cells [J].
Bellido, T ;
Stahl, N ;
Farruggella, TJ ;
Borba, V ;
Yancopoulos, GD ;
Manolagas, SC .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :431-437
[3]   EFFECTS OF THYROCALCITONIN AND PHOSPHATE ION ON PARATHYROID-HORMONE STIMULATED RESORPTION OF BONE [J].
BRAND, JS ;
RAISZ, LG .
ENDOCRINOLOGY, 1972, 90 (02) :479-+
[4]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[5]  
Conaway HH, 1998, P SOC EXP BIOL MED, V217, P153
[6]   CYTOKINE AND HORMONAL-STIMULATION OF HUMAN OSTEOSARCOMA INTERLEUKIN-11 PRODUCTION [J].
ELIAS, JA ;
TANG, WL ;
HOROWITZ, MC .
ENDOCRINOLOGY, 1995, 136 (02) :489-498
[7]   INTERLEUKIN-11 - A NEW CYTOKINE CRITICAL FOR OSTEOCLAST DEVELOPMENT [J].
GIRASOLE, G ;
PASSERI, G ;
JILKA, RL ;
MANOLAGAS, SC .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1516-1524
[8]   Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway [J].
Heinrich, PC ;
Behrmann, I ;
Müller-Newen, G ;
Schaper, F ;
Graeve, L .
BIOCHEMICAL JOURNAL, 1998, 334 :297-314
[9]   The cellular actions of interleukin-11 on bone resorption in vitro [J].
Hill, PA ;
Tumber, A ;
Papaioannou, S ;
Meikle, MC .
ENDOCRINOLOGY, 1998, 139 (04) :1564-1572
[10]   The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption [J].
Hofbauer, LC ;
Khosla, S ;
Dunstan, CR ;
Lacey, DL ;
Boyle, WJ ;
Riggs, BL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) :2-12